相关实验视频
Updated: Jul 12, 2025

10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
19.5K
益生菌显示,作为神经系统疾病的新型自然治疗方法具有前景
Preeti Jha1, Neha Dangi2, Shikha Sharma3
1Department of Biotechnology, Amity Institute of Biotechnology, Amity University, Jaipur, 303002, Rajasthan, India.
Current pharmaceutical biotechnology
|October 25, 2023
概括
益生菌,也称为精神生物,通过影响肠-大脑轴,对心理健康产生积极影响. 这篇评论探讨了它们在治疗神经系统疾病方面的潜力.
科学领域:
- 微生物学 微生物学
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 益生菌是有益的微生物,如果经常食用,会给健康带来好处.
- 这些微生物产生具有营养和药用特性的代谢物.
- 新兴的研究将益生菌与焦虑和抑郁等心理健康结果的改善联系起来.
研究的目的:
- 审查有关使用益生菌治疗神经系统疾病的现有科学证据.
- 探索精神药物在调节肠-大脑轴中的作用.
- 评估益生菌在精神和神经疾病中的治疗潜力.
主要方法:
- 对现有的科学文献进行系统审查.
- 对调查肠-大脑轴通信通路的研究进行分析.
- 检查益生菌菌株对中枢神经系统 (CNS) 的影响.
主要成果:
- 益生菌或精神生菌可以通过肠-大脑轴 (GBA) 影响心理健康.
- 特定的细菌和酵母菌株通过神经元,幽默和代谢途径调节中枢神经系统的通信.
- 有证据表明,益生菌可能有助于缓解情绪和焦虑症状.
结论:
- 精神生物药物代表了神经和精神疾病的有前途的治疗途径.
- 需要进一步的研究来验证益生菌在治疗这些疾病中的有效性.
- 肠-大脑轴为开发精神健康问题的新疗法提供了一个新的目标.
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Physiology of Enteric Nervous System and Gut Health
279
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
279
Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

